Geneos Wealth Management’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-28
Closed -$1K 3161
2021
Q1
$1K Buy
+28
New +$1.56K ﹤0.01% 3083

Other funds holding SILK

Geneos Wealth Management's SILK Position: Q2 2021 in Review

Geneos Wealth Management sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q2 2021, closing a stake of 28 shares — an estimated $1K sold.

Geneos Wealth Management first reported a position in SILK in Q1 2021 and held it in 1 quarter. The position peaked at $1K in Q1 2021. 155 funds tracked by Wall St. Rank hold SILK as of Q2 2021.

  • Geneos Wealth Management reported no remaining Silk Road Medical, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Geneos Wealth Management sold 28 Silk Road Medical, Inc. Common Stock shares in Q2 2021, an estimated $1K.
  • Geneos Wealth Management first reported a position in Silk Road Medical, Inc. Common Stock in Q1 2021 and held it in 1 quarter.
  • Geneos Wealth Management's Silk Road Medical, Inc. Common Stock position peaked at $1K in Q1 2021.
  • 155 funds tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q2 2021.

Based on Geneos Wealth Management's 13F filing for Q2 2021, filed 8 Jul 2021.